Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00166
|
|||||
| Drug Name |
Edoxaban
|
|||||
| Synonyms |
Edoxaban
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Atrial fibrillation [ICD11: BC81.3] | Approved | [1] | |||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C24H30ClN7O4S
|
|||||
| Canonical SMILES |
CN1CCC2=C(C1)SC(=N2)C(=O)NC3CC(CCC3NC(=O)C(=O)NC4=NC=C(C=C4)Cl)C(=O)N(C)C
|
|||||
| InChI |
InChI=1S/C24H30ClN7O4S/c1-31(2)24(36)13-4-6-15(27-20(33)21(34)30-19-7-5-14(25)11-26-19)17(10-13)28-22(35)23-29-16-8-9-32(3)12-18(16)37-23/h5,7,11,13,15,17H,4,6,8-10,12H2,1-3H3,(H,27,33)(H,28,35)(H,26,30,34)/t13-,15-,17+/m0/s1
|
|||||
| InChIKey |
HGVDHZBSSITLCT-JLJPHGGASA-N
|
|||||
| CAS Number |
CAS 912273-65-5
|
|||||
| Pharmaceutical Properties | Molecular Weight | 548.1 | Topological Polar Surface Area | 165 | ||
| Heavy Atom Count | 37 | Rotatable Bond Count | 5 | |||
| Hydrogen Bond Donor Count | 3 | Hydrogen Bond Acceptor Count | 8 | |||
| XLogP |
1.4
|
|||||
| PubChem CID | ||||||
| PubChem SID |
109693269
, 123092995
, 123107846
, 124490450
, 135263753
, 141477305
, 152343994
, 15285745
, 162198449
, 163409416
, 163620696
, 163686010
, 163909302
, 170502825
, 172096222
, 172121849
, 185988955
, 198981897
, 198992538
, 223365911
, 223397933
, 223922733
, 22657909
, 226666786
, 249273064
, 249736672
, 249865853
, 252090008
, 252150280
, 252451702
, 252552142
, 35552742
, 75383420
|
|||||
| ChEBI ID |
ChEBI:85973
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | P-GP | Transporter Info | P-glycoprotein 1 | Substrate | [2] | |
| References | ||||||
| 1 | Edoxaban was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
| 2 | Edoxaban drug-drug interactions with ketoconazole, erythromycin, and cyclosporine. Br J Clin Pharmacol. 2016 Dec;82(6):1591-1600. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.